ly 300164 has been researched along with 6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione in 1 studies
Studies (ly 300164) | Trials (ly 300164) | Recent Studies (post-2010) (ly 300164) | Studies (6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione) | Trials (6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione) | Recent Studies (post-2010) (6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione) |
---|---|---|---|---|---|
73 | 7 | 12 | 36 | 1 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inami, H; Kato, K; Ohno, K; Sakamoto, S; Shishikura, J; Yamashita, H; Yasunaga, T | 1 |
1 other study(ies) available for ly 300164 and 6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione
Article | Year |
---|---|
Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists.
Topics: Animals; Anticonvulsants; Antinematodal Agents; Cells, Cultured; Electroshock; Hippocampus; Kainic Acid; Mice; Neurons; Pyridines; Rats; Receptors, AMPA; Seizures; Structure-Activity Relationship; Thiazines | 2015 |